| L0001-0007 | Linagliptin impurity E | 2408969-15-1 | Impurity |
| L0001-0024 | Linagliptin Impurity V | 2165549-58-4 | Impurity |
| L0001-0027 | Linagliptin Impurity 1 | 2436762-89-7 | Impurity |
| L0001-0036 | Linagliptin Impurity 3 | 668269-51-0 | Impurity |
| L0001-0039 | Linagliptin Dimer Impurity 4 | 26-10-8 | Impurity |
| L0001-0042 | Linagliptin Impurity 4 | 2749405-42-1 | Impurity |
| L0001-0050 | Linagliptin Dimer Impurity 6 | 1643364-41-3 | Impurity |
| L0001-0062 | Linagliptin Impurity 10 CRS | 668270-11-9 | Impurity |
| L0001-0065 | Linagliptin Impurity 11 CRS | 1646355-34-1 | Impurity |
| L0001-0066 | Linagliptin Impurity 12 | 2279114-31-5 | Impurity |
| L0001-0075 | Linagliptin Impurity 18 | 6140-11-0 | Impurity |
| L0001-0077 | Linagliptin Impurity 20 | 2514949-81-4 | Impurity |
| L0001-0090 | Linagliptin Impurity 30 | 1573118-33-8 | Impurity |
| L0001-0091 | Linagliptin Impurity 30 CRS | 1911621-52-7 | Impurity |
| L0001-0094 | Linagliptin Impurity 32 | 13535-91-6 | Impurity |
| L0001-0107 | Linagliptin Impurity 43 | 1979144-52-9 | Impurity |
| L0001-0111 | Linagliptin Impurity 45 | 2463617-43-6 | Impurity |
| L0001-0112 | Linagliptin Impurity 46 | 2489212-72-6 | Impurity |
| L0001-0117 | Linagliptin Impurity 49 | 2446799-71-7 | Impurity |
| L0001-0121 | Linagliptin Impurity 51 | 2138392-83-1 | Impurity |
| L0001-0124 | Linagliptin Impurity 53 | 586408-08-4 | Impurity |
| L0001-0142 | Linagliptin Impurity 69 | 2444011-29-2 | Impurity |
| L0001-0145 | Linagliptin Impurity 71 | 2468656-63-3 | Impurity |
| L0001-0157 | Linagliptin Impurity 80 | 2428491-17-0 | Impurity |
| L0001-0161 | Linagliptin Impurity 83 | 923256-22-8 | Impurity |
| L0001-0167 | Linagliptin Impurity 89 | 168466-84-0 | Impurity |
| L0001-0173 | Linagliptin Impurity 91 | 54012-73-6 | Impurity |
| L0001-0175 | Linagliptin Impurity 91 Dihydrochloride | 138060-07-8 | Impurity |
| L0001-0176 | Linagliptin Impurity 91 Hydrochloride | 150395-91-8 | Impurity |
| L0001-0178 | Linagliptin Impurity 92 | 2138805-26-0 | Impurity |
| L0001-0193 | Linagliptin Impurity 104 | 2074688-84-7 | Impurity |
| L0001-0202 | Linagliptin Impurity 113 | 2382729-41-9 | Impurity |
| L0001-0206 | Linagliptin Impurity 115 | 2074688-80-3 | Impurity |
| L0001-0207 | Linagliptin Impurity 116 | 2279114-30-4 | Impurity |
| L0001-0212 | Linagliptin Impurity 119 | 1439816-95-1 | Impurity |
| L0001-0214 | Linagliptin Impurity 121 | 2434-53-9 | Impurity |
| L0001-0219 | Linagliptin Impurity 125 | 287192-97-6 | Impurity |
| L0001-0221 | Linagliptin Impurity 126 | 1039741-10-0 | Impurity |
| L0001-0223 | Linagliptin Impurity 127 | 3355-28-0 | Impurity |
| L0001-0225 | Linagliptin Impurity 128 | 764-01-2 | Impurity |
| L0001-0229 | Linagliptin Impurity 133 | 2517759-32-7 | Impurity |
| L0001-0233 | Linagliptin Impurity 136 | 2763799-91-1 | Impurity |
| L0001-0281 | Linagliptin Impurity 193 | 188869-05-8 | Impurity |
| L0001-0309 | Linagliptin Impurity 222 | 2228984-94-7 | Impurity |
| L0001-0326 | Linagliptin Impurity 242 | 77350-93-7 | Impurity |
| L0001-0338 | Linagliptin Impurity 255 | 2983074-57-1 | Impurity |
| L0001-0344 | Linagliptin Impurity 2 | 1803079-49-3 | Impurity |
| L0001-0348 | Linagliptin-d3 | 1398044-48-8 | Stable-isotope labelled analogue |
| L0001-0423 | Linagliptin Impurity 232 | 6278-37-1 | Impurity |
| L0001-0436 | Linagliptin Metabolite CD10604 | 1807608-27-0 | Metabolite |
| L0001-0444 | (E)-1,3-Dibromobut-2-ene | 86365-83-5 | Related substance |
| L0001-0446 | (E)-8-Bromo-7-(3-bromobut-2-en-1-yl)-3-methyl-1H-purine-2,6(3H,7H)-dione | 504-61-0 | Related substance |
| L0001-0456 | (R)-2-((1-(7-(but-2-yn-1-yl)-3-methyl-1-((4-methylquinazolin-2-yl)methyl)-2,6-dioxo-2,3,6,7-tetrahydro-1H-purin-8-yl)piperidin-3-yl)carbamoyl)benzoic acid | 2074688-81-4 | Related substance |
| L0001-0462 | (R)-3-Boc-Aminopiperidine | 309956-78-3 | Related substance |
| L0001-0466 | (R)-7-(but-2-yn-1-yl)-3-methyl-1-((4-methylquinazolin-2-yl)methyl)-8-(3-nitropiperidin-1-yl)-3,7-dihydro-1H-purine-2,6-dione | 2983074-61-7 | Related substance |
| L0001-0469 | (R)-7-(but-2-yn-1-yl)-3-methyl-1-((4-methylquinazolin-2-yl)methyl)-8-(piperidin-3-ylamino)-3,7-dihydro-1H-purine-2,6-dione | 1446263-38-2 | Related substance |
| L0001-0471 | (R)-7-(but-2-yn-1-yl)-3-methyl-1-((4-methylquinazolin-2-yl-2-14C)methyl)-8-(3-nitrosopiperidin-1-yl)-3,7-dihydro-1H-purine-2,6-dione | 1297273-94-9 | Related substance |
| L0001-0473 | (R)-7-(but-2-yn-1-yl)-8-(3-((7-(but-2-yn-1-yl)-3-methyl-1-((4-methylquinazolin-2-yl)methyl)-2,6-dioxo-2,3,6,7-tetrahydro-1H-purin-8-yl)amino)piperidin-1-yl)-3-methyl-1-((4-methylquinazolin-2-yl)methyl)-3,7-dihydro-1H-purine-2,6-dione | 2253964-98-4 | Related substance |
| L0001-0475 | (R)-7-(but-2-yn-1-yl)-8-(3-(1,3-dioxoisoindolin-2-yl)piperidin-1-yl)-3-methyl-1-((4-methylquinazolin-2-yl)methyl)-3,7-dihydro-1H-purine-2,6-dione | 886588-63-2 | Related substance |
| L0001-0486 | (R)-7-(but-2-yn-1-yl)-8-(3-hydroxypiperidin-1-yl)-3-methyl-1-((4-methylquinazolin-2-yl)methyl)-3,7-dihydro-1H-purine-2,6-dione | 2803369-89-1 | Related substance |
| L0001-0493 | (R)-8-(3-Aminopiperidin-1-yl)-3,7-dimethyl-1-((4-methylquinazolin-2-yl)methyl)-1H-purine-2,6(3H,7H)-dione | 1339955-47-3 | Related substance |
| L0001-0507 | (R)-8-(3-aminopiperidin-1-yl)-3-methyl-7-((4-methylquinazolin-2-yl)methyl)-3,7-dihydro-1H-purine-2,6-dione | 2748491-45-2 | Related substance |
| L0001-0510 | (R)-8-(3-aminopiperidin-1-yl)-7-(4-hydroxybut-2-yn-1-yl)-3-methyl-1-((4-methylquinazolin-2-yl)methyl)-3,7-dihydro-1H-purine-2,6-dione | 1807608-59-8 | Related substance |
| L0001-0519 | (R)-8-(3-aminopiperidin-1-yl)-7-(but-2-yn-1-yl)-3-methyl-1-((4-methylquinazolin-2-yl)methyl)-3,7-dihydro-1H-purine-2,6-dione | 668270-12-0 | Related substance |
| L0001-0520 | (R)-8-(3-aminopiperidin-1-yl)-7-(but-2-yn-1-yl)-3-methyl-1-(quinazolin-2-ylmethyl)-3,7-dihydro-1H-purine-2,6-dione | 668269-50-9 | Related substance |
| L0001-0523 | (R)-8-(3-aminopiperidin-1-yl)-7-(but-2-yn-1-yl)-3-methyl-2-((4-methylquinazolin-2-yl)methoxy)-3,7-dihydro-6H-purin-6-one | 2446799-72-8 | Related substance |
| L0001-0525 | (R)-8-(3-aminopiperidin-1-yl)-7-(but-2-yn-1-yl)-3-methyl-3,7-dihydro-1H-purine-2,6-dione | 1791405-13-4 | Related substance |
| L0001-0527 | (R)-8-(3-aminopiperidin-1-yl)-7-(but-2-yn-1-yl)-3-methyl-6-((4-methylquinazolin-2-yl)methoxy)-3,7-dihydro-2H-purin-2-one | 2514724-20-8 | Related substance |
| L0001-0535 | (R)-Diethyl 2-((tert-butoxycarbonyl)amino)pentanedioate | 93720-76-4 | Related substance |
| L0001-0539 | (R)-N-(1-(7-(but-2-yn-1-yl)-3-methyl-1-((4-methylquinazolin-2-yl)methyl)-2,6-dioxo-2,3,6,7-tetrahydro-1H-purin-8-yl)piperidin-3-yl)-2,2,2-trifluoroacetamide | 1673546-62-7 | Related substance |
| L0001-0542 | (R)-N-(1-(7-(but-2-yn-1-yl)-3-methyl-1-((4-methylquinazolin-2-yl)methyl)-2,6-dioxo-2,3,6,7-tetrahydro-1H-purin-8-yl)piperidin-3-yl)formamide | 3037659-49-4 | Related substance |
| L0001-0544 | (R)-N-(2-acetylphenyl)-2-(8-(3-aminopiperidin-1-yl)-7-(but-2-yn-1-yl)-3-methyl-2,6-dioxo-2,3,6,7-tetrahydro-1H-purin-1-yl)acetamide | 2416949-69-2 | Related substance |
| L0001-0550 | (R)-piperidin-3-amine | 127294-73-9 | Related substance |
| L0001-0551 | (R)-piperidin-3-amine Dihydrochloride | 334618-23-4 | Salt / salt form |
| L0001-0564 | (R)-tert-Butyl Piperidin-3-ylcarbamate Hydrochloride | 1217656-59-1 | Salt / salt form |
| L0001-0566 | (R,E)-8-(3-aminopiperidin-1-yl)-7-(3-bromobut-2-en-1-yl)-3-methyl-1-((4-methylquinazolin-2-yl)methyl)-3,7-dihydro-1H-purine-2,6-dione | 1446263-39-3 | Related substance |
| L0001-0573 | (R,Z)-8-(3-aminopiperidin-1-yl)-7-(3-bromobut-2-en-1-yl)-3-methyl-1-((4-methylquinazolin-2-yl)methyl)-3,7-dihydro-1H-purine-2,6-dione | 1638744-06-5 | Related substance |
| L0001-0574 | (R,Z)-8-(3-aminopiperidin-1-yl)-7-(3-chlorobut-2-en-1-yl)-3-methyl-1-((4-methylquinazolin-2-yl)methyl)-3,7-dihydro-1H-purine-2,6-dione | 2983074-54-8 | Related substance |
| L0001-0590 | (Z)-2-Buten-1-ol | 4088-60-2 | Related substance |
| L0001-0607 | 1-(1-(7-(but-2-yn-1-yl)-3-methyl-1-((4-methylquinazolin-2-yl)methyl)-2,6-dioxo-2,3,6,7-tetrahydro-1H-purin-8-yl)piperidin-3-yl)urea | 1955514-80-3 | Related substance |
| L0001-0611 | 1-(2-aminophenyl)ethan-1-one | 551-93-9 | Related substance |
| L0001-0615 | 1-Piperidinecarboxylic acid, 3-[[7-(2-butyn-1-yl)-2,3,6,7-tetrahydro-3-methyl-1-[(4-methyl-2-quinazolinyl)methyl]-2,6-dioxo-1H-purin-8-yl]amino]-, 1,1-dimethylethyl ester, (3S) | 2815578-97-1 | Related substance |
| L0001-0617 | 1H-Purine-2,6-dione, 8-bromo-7-(2-butyn-1-yl)-3,7-dihydro-3-methyl-1-(2-quinazolinylmethyl) | 1911609-81-8 | Related substance |
| L0001-0620 | 2-((2-acetylphenyl)amino)acetonitrile | 88203-04-7 | Related substance |
| L0001-0622 | 2-((R)-3-aminopiperidine-1-carbonyl)-N-((R)-1-(7-(but-2-yn-1-yl)-3-methyl-1-((4-methylquinazolin-2-yl)methyl)-2,6-dioxo-2,3,6,7-tetrahydro-1H-purin-8-yl)piperidin-3-yl)benzamide | 2803370-12-7 | Related substance |
| L0001-0624 | 2-((R)-3-aminopiperidine-1-carbonyl)-N-((R)-1-(7-(but-2-yn-1-yl)-3-methyl-1-((4-methylquinazolin-2-yl)methyl)-2,6-dioxo-2,3,6,7-tetrahydro-1H-purin-8-yl)piperidin-3-yl)benzamide | 2443735-53-1 | Related substance |
| L0001-0628 | 2-(chloromethyl)-4-[3-[2-(chloromethyl)quinazolin-4-yl]-2-methylpropyl]quinazoline | 2638512-67-9 | Related substance |
| L0001-0630 | 2-(chloromethyl)-4-methylquinazoline | 109113-72-6 | Related substance |
| L0001-0631 | 2-(chloromethyl)-4-methylquinazoline 3-oxide | 6640-59-1 | Related substance |
| L0001-0642 | 3-Piperidinamine, 1-nitroso-, (3R)-, 2,2,2-trifluoroacetate (1:1) | 3031851-93-8 | Related substance |
| L0001-0643 | 3031851-93-8(Trifluoroacetate) | 3031851-91-6 | Related substance |
| L0001-0648 | 7-(2-Butyn-1-yl)-3,7-dihydro-3-methyl-1-[(4-methyl-2-quinazolinyl)methyl]-8-[(3S)-3-piperidinylamino]-1H-purine-2,6-dione | 2253964-85-9 | Related substance |
| L0001-0655 | 7-(but-2-yn-1-yl)-3-Methyl-1-((4-methylquinazolin-2-yl)methyl)-8-((3R)-3-(((Z)-2,3,4,5,6-pentahydroxyhex-1-en-1-yl)amino)piperidin-1-yl)-3,7-dihydro-1H-purine-2,6-dione | 40673-76-5 | Related substance |
| L0001-0663 | 7-(but-2-yn-1-yl)-3-methyl-1-((4-methylquinazolin-2-yl)methyl)-8-(piperidin-1-yl)-3,7-dihydro-1H-purine-2,6-dione | 1803079-47-1 | Related substance |
| L0001-0696 | 8-((R)-3-aminopiperidin-1-yl)-1-((4-((2-((8-((R)-3-aminopiperidin-1-yl)-7-(but-2-yn-1-yl)-3-methyl-2,6-dioxo-2,3,6,7-tetrahydro-1H-purin-1-yl)methyl)-4-methyl-1,4-dihydroquinazolin-4-yl)methyl)quinazolin-2-yl)methyl)-7-(but-2-yn-1-yl)-3-methyl-3,7-dihydro-1H-purine-2,6-dione | 1418133-47-7 | Related substance |
| L0001-0711 | 8-((R)-3-aminopiperidin-1-yl)-7-(but-2-yn-1-yl)-1-((4-(2-(((R)-1-(7-(but-2-yn-1-yl)-3-methyl-1-((4-methylquinazolin-2-yl)methyl)-2,6-dioxo-2,3,6,7-tetrahydro-1H-purin-8-yl)piperidin-3-yl)amino)ethyl)quinazolin-2-yl)methyl)-3-methyl-3,7-dihydro-1H-purine-2,6-dione | 2463617-49-2 | Related substance |
| L0001-0740 | 8-bromo-3-methyl-7H-purine-2,6-dione | 93703-24-3 | Related substance |
| L0001-0741 | 8-Bromo-7-(2-butyn-1-yl)-3-methylxanthine] | 666816-98-4 | Related substance |
| L0001-0749 | 8-bromo-7-but-2-ynyl-3-methyl-1-[(4-methylquinazolin-2-yl)methyl]purine-2,6-dione | 853029-57-9 | Related substance |
| L0001-0753 | 8-bromo-9-(but-2-yn-1-yl)-3-methyl-1H-purine-2,6(3H,9H)-dione | 2512206-89-0 | Related substance |
| L0001-0762 | Hydroxy Methyl Linagliptin | 20-19-9 | Related substance |
| L0001-0767 | Linagliptin Dimer (Racemic Mixture) | 2759280-92-5 | Related substance |
| L0001-0778 | Linagliptin Metabolite 476(1) | 1807607-07-3 | Metabolite |
| L0001-0781 | Linagliptin Metabolite 504(2) | 1807607-25-5 | Metabolite |
| L0001-0796 | Linagliptin Stereochemical Impurity | 1383917-84-7 | Impurity |
| L0001-0809 | N-(1-(7-(but-2-yn-1-yl)-3-methyl-1-((4-methylquinazolin-2-yl)methyl)-2,6-dioxo-2,3,6,7-tetrahydro-1H-purin-8-yl)piperidin-3-yl)formamide | 2137744-33-1 | Related substance |
| L0001-0816 | N-(2-Acetylphenyl)acetamide | 5234-26-4 | Related substance |
| L0001-0817 | N-(3-acetylphenyl)-2-chloroacetamide | 42865-69-0 | Related substance |
| L0001-0818 | N-(6-amino-1-methyl-2,4-dioxo-1,2,3,4-tetrahydropyrimidin-5-yl)formamide | 14785-95-6 | Related substance |
| L0001-0821 | N-Aminoacyl Linagliptin | 2983074-55-9 | Related substance |
| L0001-0824 | N-Nitroso Linagliptin Impurity | 3031851-92-7 | Impurity |
| L0001-0828 | N1,N2-bis((R)-1-(7-(but-2-yn-1-yl)-3-methyl-1-((4-methylquinazolin-2-yl)methyl)-2,6-dioxo-2,3,6,7-tetrahydro-1H-purin-8-yl)piperidin-3-yl)phthalamide | 2074688-82-5 | Related substance |
| L0001-0830 | Quinazoline, 2-(Chloromethyl) | 6148-18-1 | Related substance |
| L0001-0833 | tert-butyl ((3R)-1-(7-(but-2-yn-1-yl)-1-((4-((2-((7-(but-2-yn-1-yl)-8-((R)-3-((tert-butoxycarbonyl)amino)piperidin-1-yl)-3-methyl-2,6-dioxo-2,3,6,7-tetrahydro-1H-purin-1-yl)methyl)-4-methyl-4,4a-dihydroquinazolin-4-yl)methyl)quinazolin-2-yl)methyl)-3-methyl-2,6-dioxo-2,3,6,7-tetrahydro-1H-purin-8-yl)piperidin-3-yl)carbamate | 2414268-69-0 | Related substance |
| L0001-0839 | tert-butyl (4-((2,6-dimethyl-3-propionamidopyridin-4-yl)amino)phenethyl)carbamate | 2408731-74-6 | Related substance |
| L0001-0840 | tert-butyl (4-((3-amino-2,6-dimethylpyridin-4-yl)amino)phenethyl)carbamate | 2408731-72-4 | Related substance |
| L0001-0841 | tert-butyl (4-((3-amino-2,6-dimethylpyridin-4-yl)amino)phenethyl)carbamate hydrochloride | 2408731-88-2 | Salt / salt form |
| L0001-0842 | tert-butyl (R)-(1-(1,7-di(but-2-yn-1-yl)-3-methyl-2,6-dioxo-2,3,6,7-tetrahydro-1H-purin-8-yl)piperidin-3-yl)carbamate | 2518331-40-1 | Related substance |
| L0001-0843 | tert-butyl (R)-(1-(1-(2-((2-acetylphenyl)amino)-2-oxoethyl)-7-(but-2-yn-1-yl)-3-methyl-2,6-dioxo-2,3,6,7-tetrahydro-1H-purin-8-yl)piperidin-3-yl)carbamate | 2279114-27-9 | Related substance |
| L0001-0846 | tert-butyl (R)-(1-(3-methyl-7-((4-methylquinazolin-2-yl)methyl)-2,6-dioxo-2,3,6,7-tetrahydro-1H-purin-8-yl)piperidin-3-yl)carbamate | 2748381-67-9 | Related substance |
| L0001-0848 | tert-butyl (R)-(1-(7-(but-2-yn-1-yl)-3-methyl-1-((4-methylquinazolin-2-yl)methyl)-2,6-dioxo-2,3,6,7-tetrahydro-1H-purin-8-yl)piperidin-3-yl)carbamate | 668273-75-4 | Related substance |
| L0001-0849 | tert-butyl (R)-(1-(7-(but-2-yn-1-yl)-3-methyl-2,6-dioxo-2,3,6,7-tetrahydro-1H-purin-8-yl)piperidin-3-yl)carbamate | 666816-91-7 | Related substance |
| L0001-0852 | Tert-butyl (R)-(1-(quinazolin-2-ylmethyl)piperidin-3-yl)carbamate | 21-15-8 | Related substance |
| L0001-0854 | tert-butyl (R)-3-aminopiperidine-1-carboxylate | 188111-79-7 | Related substance |
| L0001-0856 | tert-butyl (R,Z)-(1-(7-(3-bromobut-2-en-1-yl)-3-methyl-1-((4-methylquinazolin-2-yl)methyl)-2,6-dioxo-2,3,6,7-tetrahydro-1H-purin-8-yl)piperidin-3-yl)carbamate | 2803372-57-6 | Related substance |
| L0001-0857 | tert-butyl (S)-(1-(7-(but-2-yn-1-yl)-3-methyl-1-((4-methylquinazolin-2-yl)methyl)-2,6-dioxo-2,3,6,7-tetrahydro-1H-purin-8-yl)piperidin-3-yl)carbamate | 668273-74-3 | Related substance |
| L0001-0858 | tert-Butyl N-(1-benzylpiperidin-3-yl)carbamate | 478828-62-5 | Related substance |
| L0001-0867 | Linagliptin Impurity 144 | 2819242-71-0 | Impurity |